Deutsche Bank’s CalciMedica CALC Stock Holding History

Deutsche Bank’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-60	Closed	-$23K	–	4614
2021 Q1	$23K	Sell	60 -5	-8%	-$7.48K	﹤0.01%	4368
2020 Q4	$133K	Buy	+65	New	+$95.9K	﹤0.01%	3692

Other funds holding CALC

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

JJIJ

Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return

Deutsche Bank's CALC Position: Q2 2021 in Review

Deutsche Bank sold out of CalciMedica (CALC) in Q2 2021, closing a stake of 60 shares — an estimated $23K sold.

Deutsche Bank first reported a position in CALC in Q4 2020 and held it in 2 quarters. The position peaked at $133K in Q4 2020. 41 funds tracked by Wall St. Rank hold CALC as of Q2 2021.

Deutsche Bank reported no remaining CalciMedica position as of Q2 2021 after selling out during the quarter.
Deutsche Bank sold 60 CalciMedica shares in Q2 2021, an estimated $23K.
Deutsche Bank first reported a position in CalciMedica in Q4 2020 and held it in 2 quarters.
Deutsche Bank's CalciMedica position peaked at $133K in Q4 2020.
41 funds tracked by Wall St. Rank held CalciMedica as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.